Table 1 Main clinical characteristics of... | American Society of Hematology

Table 1

Main clinical characteristics of cHL patients, N = 49

Characteristic	No.	%
Median age, y (range)	32 (15-80)
Sex, M/F	27/22	55/45
Histology
Nodular sclerosis	37	76
Mixed cellularity	12	24
EBV⁺*	16	36
B symptoms	25	51
Bulky mass	11	22
Anemia, Hb level less than 10⁵ g/L	12	24
Leukocytosis, more than 15 × 10⁹/L	9	18
Lymphocytopenia, less than 0.6 × 10⁹/L or less than 8% of WBC	7	14
Hypoalbuminemia, less than 40 g/L	17	36
High LDH level, more than 450 UI/L	18	37
High β-2-microblobulin level, more than 25 mg/L	12	29
Stage III-IV	23	47
Hasenclever index more than 3†	12	33

Characteristic	No.	%
Median age, y (range)	32 (15-80)
Sex, M/F	27/22	55/45
Histology
Nodular sclerosis	37	76
Mixed cellularity	12	24
EBV⁺*	16	36
B symptoms	25	51
Bulky mass	11	22
Anemia, Hb level less than 10⁵ g/L	12	24
Leukocytosis, more than 15 × 10⁹/L	9	18
Lymphocytopenia, less than 0.6 × 10⁹/L or less than 8% of WBC	7	14
Hypoalbuminemia, less than 40 g/L	17	36
High LDH level, more than 450 UI/L	18	37
High β-2-microblobulin level, more than 25 mg/L	12	29
Stage III-IV	23	47
Hasenclever index more than 3†	12	33

WBC indicates white blood cell.

Nine (26%) of 34 nodular sclerosis versus 7 (70%) of 10 mixed cellularity (P = .01).

Calculated only in 36 patients with advanced disease (stages III-IV, B symptoms, or bulky mass).